140 related articles for article (PubMed ID: 11248009)
1. Calcineurin inhibition and cardiac hypertrophy: a matter of balance.
Leinwand LA
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):2947-9. PubMed ID: 11248009
[No Abstract] [Full Text] [Related]
2. Old and new tools to dissect calcineurin's role in pressure-overload cardiac hypertrophy.
Zhang W
Cardiovasc Res; 2002 Feb; 53(2):294-303. PubMed ID: 11827679
[TBL] [Abstract][Full Text] [Related]
3. Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo.
De Windt LJ; Lim HW; Bueno OF; Liang Q; Delling U; Braz JC; Glascock BJ; Kimball TF; del Monte F; Hajjar RJ; Molkentin JD
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3322-7. PubMed ID: 11248077
[TBL] [Abstract][Full Text] [Related]
4. Calcineurin inhibition in hypertrophy: back from the dead!
Dorn GW
Circulation; 2001 Jul; 104(1):9-11. PubMed ID: 11435329
[No Abstract] [Full Text] [Related]
5. [Hypertrophy of the heart: calcineurin-NFAT pathway may be a new therapeutic target].
Zhang YJ; Dong LF; Wang YL
Yao Xue Xue Bao; 2006 Oct; 41(10):913-6. PubMed ID: 17184105
[No Abstract] [Full Text] [Related]
6. Calcineurin inhibitors and cardiac hypertrophy.
Force T; Rosenzweig A; Choukroun G; Hajjar R
Lancet; 1999 Apr; 353(9161):1290-2. PubMed ID: 10218524
[No Abstract] [Full Text] [Related]
7. Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT.
Crabtree GR
Cell; 1999 Mar; 96(5):611-4. PubMed ID: 10089876
[No Abstract] [Full Text] [Related]
8. Control of cardiac growth and function by calcineurin signaling.
Vega RB; Bassel-Duby R; Olson EN
J Biol Chem; 2003 Sep; 278(39):36981-4. PubMed ID: 12881512
[No Abstract] [Full Text] [Related]
9. Multiple roles of the DSCR1 (Adapt78 or RCAN1) gene and its protein product calcipressin 1 (or RCAN1) in disease.
Harris CD; Ermak G; Davies KJ
Cell Mol Life Sci; 2005 Nov; 62(21):2477-86. PubMed ID: 16231093
[TBL] [Abstract][Full Text] [Related]
10. The role of modulatory calcineurin-interacting proteins in calcineurin signaling.
Rothermel BA; Vega RB; Williams RS
Trends Cardiovasc Med; 2003 Jan; 13(1):15-21. PubMed ID: 12554096
[TBL] [Abstract][Full Text] [Related]
11. Prevention of cardiac hypertrophy in mice by calcineurin inhibition.
Sussman MA; Lim HW; Gude N; Taigen T; Olson EN; Robbins J; Colbert MC; Gualberto A; Wieczorek DF; Molkentin JD
Science; 1998 Sep; 281(5383):1690-3. PubMed ID: 9733519
[TBL] [Abstract][Full Text] [Related]
12. Calcineurin--the missing link in cardiac hypertrophy.
Izumo S; Aoki H
Nat Med; 1998 Jun; 4(6):661-2. PubMed ID: 9623967
[No Abstract] [Full Text] [Related]
13. [Calcineurin inhibitors and calcineurin-NFAT system].
Amasaki Y
Nihon Rinsho Meneki Gakkai Kaishi; 2010; 33(5):249-61. PubMed ID: 21048386
[TBL] [Abstract][Full Text] [Related]
14. Endogenous protein inhibitors of calcineurin.
Liu JO
Biochem Biophys Res Commun; 2003 Nov; 311(4):1103-9. PubMed ID: 14623296
[TBL] [Abstract][Full Text] [Related]
15. An immunosuppressive triumvirate to minimize renal injuries associated with calcineurin antagonist therapy.
Kahan BD
Transplantation; 1999 Jul; 68(1):12-4. PubMed ID: 10428260
[No Abstract] [Full Text] [Related]
16. Carabin: Endogenous calcineurin inhibitor, a potential diagnostic and therapeutic target for cardiac hypertrophy in heart failure.
Yi X; Li X; Jiang X
Int J Cardiol; 2016 Jun; 212():57-8. PubMed ID: 27031820
[No Abstract] [Full Text] [Related]
17. A small molecular activator of cardiac hypertrophy uncovered in a chemical screen for modifiers of the calcineurin signaling pathway.
Bush E; Fielitz J; Melvin L; Martinez-Arnold M; McKinsey TA; Plichta R; Olson EN
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):2870-5. PubMed ID: 14976250
[TBL] [Abstract][Full Text] [Related]
18. Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy.
Vega RB; Rothermel BA; Weinheimer CJ; Kovacs A; Naseem RH; Bassel-Duby R; Williams RS; Olson EN
Proc Natl Acad Sci U S A; 2003 Jan; 100(2):669-74. PubMed ID: 12515860
[TBL] [Abstract][Full Text] [Related]
19. Cryptococcus neoformans isolates from transplant recipients are not selected for resistance to calcineurin inhibitors by current immunosuppressive regimens.
Blankenship JR; Singh N; Alexander BD; Heitman J
J Clin Microbiol; 2005 Jan; 43(1):464-7. PubMed ID: 15635017
[TBL] [Abstract][Full Text] [Related]
20. [Topic calcineurin inhibitors].
Fonseca E
Med Clin (Barc); 2003 Mar; 120(7):255-6. PubMed ID: 12623001
[No Abstract] [Full Text] [Related]
[Next] [New Search]
